
    
      PRIMARY OBJECTIVE:

      I. Define the feasibility of the current photoacoustic imaging (PAI) technology in head and
      neck (H&N) cancer patients.

      SECONDARY OBJECTIVE:

      I. Define the utility of the current PAI in H&N cancer patients.

      OUTLINE:

      PART I: Patients undergo PAI before the start of chemoradiation therapy, weekly during 7
      weeks of chemoradiation, and again 3-4 months after completion of chemoradiation therapy.

      PART II (CANCER-FREE WITH XEROSTOMIA): Patients undergo PAI at baseline, up to twice during
      acupuncture-like transcutaneous nerve stimulation (ALTENS) therapy, once after ALTENS, and at
      3-6 months follow up.
    
  